Published online Feb 28, 2015. doi: 10.3748/wjg.v21.i8.2425
Peer-review started: August 13, 2014
First decision: September 27, 2014
Revised: October 2, 2014
Accepted: October 21, 2014
Article in press: October 21, 2014
Published online: February 28, 2015
Processing time: 199 Days and 17.5 Hours
AIM: To report the incidence and potential risk factors of small-volume chylous ascites (SVCA) following laparoscopic radical gastrectomy (LAG).
METHODS: A total of 1366 consecutive gastric cancer patients who underwent LAG from January 2008 to June 2011 were enrolled in this study. We analyzed the patients based on the presence or absence of SVCA.
RESULTS: SVCA was detected in 57 (4.17%) patients, as determined by the small-volume drainage (range, 30-100 mL/24 h) of triglyceride-rich fluid. Both univariate and multivariate analyses revealed that the total number of resected lymph nodes (LNs), No. 8 or No. 9 LN metastasis and N stage were independent risk factors for SVCA following LAG (P < 0.05). Regarding hospital stay, there was a significant difference between the groups with and without SVCA (P < 0.001). The 3-year disease-free and overall survival rates of the patients with SVCA were 47.4% and 56.1%, respectively, which were similar to those of the patients without SVCA (P > 0.05).
CONCLUSION: SVCA following LAG developed significantly more frequently in the patients with ≥ 32 harvested LNs, ≥ 3 metastatic LNs, or No. 8 or No. 9 LN metastasis. SVCA, which was successfully treated with conservative management, was associated with a prolonged hospital stay but was not associated with the prognosis.
Core tip: Postoperative chylous ascites (CA) following abdominal surgery is uncommon. Laparoscopic radical gastrectomy (LAG) has been increasingly used as a promising approach to manage gastric cancer. However, in the field of LAG surgery, no large studies have been conducted focusing on postoperative CA. Therefore, we conducted the current study to evaluate the incidence, management, and predisposing factors of CA, as well as the impact of CA on outcomes after LAG. This is the first study to evaluate SVCA after LAG in a large population with the aim of identifying the potential risk factors for its onset and determining the appropriate treatment.